Sun Pharmaceutical Industries Limited Price, Chart & Factor Exposure
Free Data & Analytics AccessNext earnings: Thu, Jan 28, 2027, before the market opens · estimates and history
Sun Pharmaceutical Industries Limited Forecast
Sun Pharmaceutical Industries Limited short-term momentum is neutral (up over 2 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term NEUTRAL signal. The long-term trend is negative (2 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 13.2% a year, a typical one-standard-deviation range is 1,737–1,803 over a week, 1,703–1,837 over a month and 1,536–2,004 over a year. (Signals as of 5 Nov 2026.)
Sun Pharmaceutical Industries Limited Price Chart
Sun Pharmaceutical Industries Limited Factors
YoY −5.2%
YoY −11.3%
YoY −13.3%
YoY −11.7%
YoY −13.0%
YoY +5.5%
YoY −0.5%
YoY +33.8%
YoY +21.2%
YoY +14.3%
YoY +13.2%
YoY −10.2%
YoY −45.8%
YoY +300.0%
Sun Pharmaceutical Industries Limited fundamentals: income statement, balance sheet & cash flow
Sun Pharmaceutical Industries Limited reported revenue of 584.62bn INR and net income of 114.79bn INR in FY2026, the year ended 31 March 2026 — revenue up 11.2% and net income up 5.0% on the prior year. Free cash flow was 92.42bn INR. These figures are as reported in the filings, not restated: 23 fiscal years and 62 quarters of history, back to March 2004.
| INR billions | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Revenue | 584.62 | 525.78 | 484.97 | 438.86 | 386.54 |
| Cost of revenue | 259.00 | 115.58 | 114.42 | 113.19 | 108.76 |
| Gross profit | 325.62 | 410.20 | 370.55 | 325.67 | 277.78 |
| Research & development | 34.74 | 31.54 | 31.28 | 23.08 | 21.33 |
| Selling, general & admin. | — | 100.51 | 95.02 | 83.55 | 73.54 |
| Operating income | 135.53 | 278.15 | 244.24 | 219.04 | 182.91 |
| EBITDA | 183.40 | 151.81 | 130.77 | 118.36 | 103.00 |
| Interest expense | 3.39 | 1.64 | 2.38 | 1.47 | 0.75 |
| Pre-tax income | 150.63 | 137.37 | 110.49 | 93.61 | 44.65 |
| Income tax | 35.54 | 27.72 | 14.39 | 8.48 | 10.76 |
| Net income | 114.79 | 109.29 | 95.76 | 84.74 | 32.73 |
Download Sun Pharmaceutical Industries Limited fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.SUNPHARMA.NSE&statement=all&freq=a&format=csv&years=10
Figures in INR, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.
Research on Sun Pharmaceutical Industries Limited
Explore MacroFinance macro & markets research and analysis.
Sun Pharmaceutical Industries Limited Trading Strategies
28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to Sun Pharmaceutical Industries Limited; 2 of them are invested now. Strategies currently invested are listed first.
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
Statistical Distribution of Returns
PlusHow Sun Pharmaceutical Industries Limited’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Sun Pharmaceutical Industries Limited (India)
Sun Pharmaceutical Industries Limited is a listed security in India. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
Frequently asked questions
What is Sun Pharmaceutical Industries Limited?
What is the latest Sun Pharmaceutical Industries Limited price?
Is Sun Pharmaceutical Industries Limited in an uptrend?
How volatile is Sun Pharmaceutical Industries Limited?
What factors affect Sun Pharmaceutical Industries Limited?
Which trading strategies trade Sun Pharmaceutical Industries Limited?
How are Sun Pharmaceutical Industries Limited returns analysed?
Where can I download free Sun Pharmaceutical Industries Limited historical data?
Free Sun Pharmaceutical Industries Limited historical data (last 10 years)
Browse or instantly download the last 10 years of Sun Pharmaceutical Industries Limited daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.SUNPHARMA.NSE&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 1884.9 |
| 2026-11-19 | 1900 |
| 2026-11-18 | 1871.5 |
| 2026-11-17 | 1870 |
| 2026-11-16 | 1867.5 |
| 2026-11-13 | 1880 |
| 2026-11-12 | 1885 |
| 2026-11-11 | 1902.3 |
| 2026-11-09 | 1904.5 |
| 2026-11-08 | 1915 |
About this stock
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; specialty medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers generics and APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.